Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05522075 · ClinicalTrials.gov registry record · NA

Reducing Blood Pressure in Mid-life Adult Binge Drinkers

A NA study of Aging and Blood Pressure, sponsored by The University of Texas at Arlington.

Recruiting
Registry status
NA
Development phase
55
Enrollment target
1
Study location

NCT05522075 is a NA study of Aging and Blood Pressure that is actively recruiting participants, run by The University of Texas at Arlington. The registered enrollment target is 55 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05522075, a NA study of Aging and Blood Pressure, is actively recruiting participants, sponsored by The University of Texas at Arlington.

RECRUITING
Registry status
NA
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

This study has two phases: Phase 1 is to examine blood pressure, microvascular function, and sympathetic nerve activity in mid-life adult binge drinkers vs. alcohol abstainers/moderate drinkers. Phase 2 is to examine the effect of 8-week aerobic exercise training on blood pressure, microvascular function, and sympathetic nerve activity in mid-life adult binge drinkers

Interventions

  • BEHAVIORAL Exercise Training
  • BEHAVIORAL Alcohol Abstinence Intervention

Study Locations (1)

Texas

  • University of Texas at Arlington - Arlington

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2022-11-21
Est. Completion 2026-04-30
Phase NA

What the Registry Record Tells You About NCT05522075

The ClinicalTrials.gov registry entry for NCT05522075 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower). The listed sponsor is The University of Texas at Arlington, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Exercise Training is the first listed.

NCT05522075 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05522075 about?

NCT05522075 is a clinical study titled "Reducing Blood Pressure in Mid-life Adult Binge Drinkers". This study has two phases: Phase 1 is to examine blood pressure, microvascular function, and sympathetic nerve activity in mid-life adult binge drinkers vs. alcohol abstainers/moderate drinkers. Phase 2 is to examine the effect of 8-week aerobic exercise training on blood pressure, microvascular f...

What is the current status of trial NCT05522075?

This trial is currently recruiting. It is a NA study. The enrollment target is 55 participants. The study started on 2022-11-21. Estimated completion is 2026-04-30.

What conditions does trial NCT05522075 study?

This clinical trial studies the following conditions: Aging, Blood Pressure, Alcohol Drinking, Lifestyle Factors, Vasodilation.

What interventions are being tested in trial NCT05522075?

The interventions under investigation include: Exercise Training (BEHAVIORAL), Alcohol Abstinence Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05522075?

This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05522075 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.